Navigation Links
Uptake Medical Announces First Commercial Use of InterVapor for Patients With Severe Emphysema
Date:11/29/2011

TUSTIN, Calif., Nov. 29, 2011 /PRNewswire/ -- Uptake Medical® today announced the first commercial use of the InterVapor™ System for endoscopic lung volume reduction in a patient with severe emphysema. The patient successfully underwent treatment with InterVapor, the first endoscopic lung volume reduction system for the treatment of severe emphysema that uses the body's natural healing processes without leaving foreign materials in the lung. The patient was treated by the team at the Thoraxklinik in Heidelberg, Germany, which is led by Professor Dr. Felix Herth and is recognized as a leading institution for pioneering new therapeutic options for people with emphysema. 

"As investigators in the VAPOR trial, we observed the benefits our patients received from InterVapor and we are pleased to be selected to introduce InterVapor," commented Professor Dr. Felix Herth, chief, Department of Pulmonary Medicine, Thoraxklinik Heidelberg. "It is particularly fitting that the first patient case has taken place in November, which marks COPD Awareness month, as InterVapor offers a new treatment option for patients who are looking for relief from their emphysema."

Emphysema is a progressive disease in which the lungs are permanently damaged. This leads to a condition called hyperinflation, which impacts breathing function and forces patients to take short, shallow breaths, severely impacting quality of life. The InterVapor System directly induces reduction of hyperinflation, a problem for patients with severe emphysema. InterVapor is a non-surgical procedure which treats hyperinflated parts of the lungs with heated water vapor. InterVapor triggers the body's natural healing process, gradually reducing the treated portion of the lungs and increasing the ability to breathe more fully. Unlike other approaches to lung volume reduction, InterVapor does not leave foreign materials in the lung, which may require additional procedures for adjustment or re
'/>"/>

SOURCE Uptake Medical
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Womens Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in the Menopause and Osteoporosis Markets
2. Uptake Medical Receives CE Mark for InterVapor - Endoscopic Lung Volume Reduction for Treatment of Severe Emphysema - and Announces Positive Clinical Results
3. Uptake Medical® Expands Executive Team, Announces European General Manager Lloyd Mencinger
4. Reportlinker Adds Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market
5. Reportlinker Adds Pharmaceutical Key Trends 2011 - Generics Market Overview: Patent cliff set to drive global generic uptake despite tougher market conditions
6. Uptake Medical Announces Scott Huennekens Elected to Board of Directors
7. The Harley Medical Group Sees an Uptake in Surgery Bookings for Christmas
8. Uptake Medical Names J.C. MacRae as Chief Financial Officer
9. Driven by the Uptake of Several Emerging Agents, the MRSA Drug Market Will Increase From $631 Million in 2009 to $752 Million in 2019
10. Introduction of New Products and Increased Uptake of Innovative Materials to Drive US Bone Graft Substitute Market to Nearly $2.3 Billion by 2015
11. The Continued Uptake of Key Agents Such as Januvia, Bydureon and Byetta Will Drive The Type 2 Diabetes Drug Market to Nearly Double From $19 Billion in 2009 to $36 Billion in 2019
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... 1, 2015 Nevro Corp. (NYSE: NVRO ... innovative evidence-based solutions for the treatment of chronic pain, ... offering of its common stock consisting of 1,475,506 shares ... be sold by certain of its stockholders. In addition, ... to purchase up to an additional 590,202 shares of ...
(Date:6/1/2015)... , June 1, 2015 NEOVIA ONCOLOGY ... engaged in the development and commercialization of novel, ... it has met with the U.S. Food and ... filing of an Investigational New Drug (IND) application ... a result of the meeting, Neovia has clarified ...
(Date:6/1/2015)... June 1, 2015 Novel t ... drive growth , says   GBI Research ... (NSCLC) treatment market will be driven primarily by the introduction ... treatment settings, which either replace or combine with generic chemotherapies. ... Non-Small Cell Lung Cancer Market to 2020 - ...
Breaking Medicine Technology:Nevro Announces Proposed Public Offering of Common Stock 2Nevro Announces Proposed Public Offering of Common Stock 3Neovia Oncology Announces First IND Meeting 2New Therapies to Enhance Increasingly Competitive Non-Small Cell Lung Cancer Treatment Market 2New Therapies to Enhance Increasingly Competitive Non-Small Cell Lung Cancer Treatment Market 3
... Genomic Health , Inc. (Nasdaq: GHDX ... Financial Officer, will present at the 31st Annual Canaccord ... 2011 at 11:30 a.m. Eastern Time (ET).   ... of the presentation, visit the Investor Relations section of ...
... 2011 It,s back-to-school season and for many families, ... To view the multimedia assets associated with ... (Photo: http://photos.prnewswire.com/prnh/20110804/MM45457 ) Each ... U.S. are infested with this common, six-legged critter that ...
Cached Medicine Technology:Genomic Health to Present at the Canaccord Genuity Growth Conference 2Head Lice Returns to School: Five Tips to Avoid Panic and Worry 2
(Date:6/1/2015)... (PRWEB) June 01, 2015 More than 22 ... summer months when school is out and they lose access ... Month and America’s dairy farmers and milk companies are on ... need with The Great American Milk Drive. , In ... provided in the school cafeteria for the bulk of their ...
(Date:6/1/2015)... June 01, 2015 Northridge dentist ... now offering patients a promotion on Invisalign for a ... Invisalign treatment is reduced to $3,700. Patients can find ... complimentary consultation and discuss the extent of correction they ... cannot be combined with any other offer. , ...
(Date:6/1/2015)... Listen to Volvo’s Director of Connectivity Strategy, ... more granular data to create better customer oriented services. ... in Josep Celaya Gonzalez, CIO at MAPFRE, and Silvan ... automotive insurer, MAPFRE are well versed in capturing complex ... the driver. Award winning start-up ParkTAG offer an exciting ...
(Date:6/1/2015)... June 01, 2015 Hexagon Geospatial is ... is a new cloud-based subscription service that provides on-demand ... software. , Both ERDAS IMAGINE and ... Producer Online, which offers a subscription model for delivering ... need to be able to quickly and easily access ...
(Date:6/1/2015)... 2015 The session, entitled “Building the ... vice president of Elektrobit Automotive Americas, senior representatives ... it will be moderated by Andy Gryc of CX3 ... and complexity of in-vehicle software in connected vehicles and ... and how the wider ecosystem can fit into new ...
Breaking Medicine News(10 mins):Health News:Summer Nutrition Vital for Kids who Depend on Schools for Healthy Foods 2Health News:Northridge Dentists, Drs. Michel Elyson and Ramin Assili, are Now Offering a Limited Time Promotion on Invisalign 2Health News:Complimentary Webinar: Volvo, MAPFRE and Award Winning Start-Up discuss new Frontier of In-Car Services 2Health News:Hexagon Geospatial Launches Cloud-Based Producer Online Suite 2Health News:Hexagon Geospatial Launches Cloud-Based Producer Online Suite 3Health News:Elektrobit Automotive, Ford and Delphi to Tackle In-Vehicle Software at TU-Automotive Detroit 2015 2Health News:Elektrobit Automotive, Ford and Delphi to Tackle In-Vehicle Software at TU-Automotive Detroit 2015 3
... Sept. 3 Endo Pharmaceuticals (Nasdaq: ENDP ) ... the treatment of a distinct form of bladder cancer. VALSTAR ... Calmette-Guerin (BCG)-refractory carcinoma in situ (CIS) of the ... be associated with unacceptable medical risks. VALSTAR represents a ...
... owners to warning signs of PTSD, experts say , THURSDAY, ... was unaware that she was racing dangerously down the freeway ... nose nudge her elbow. , She immediately slowed down. , ... warning her that her anxiety levels were rising, a dangerous ...
... , Briefing is the first ... , WASHINGTON, Sept. 3 The following is ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20090325/DC89081LOGO ) , ... Innovation will host a breakfast briefing on Capitol Hill titled "Education ...
... , EMERYVILLE, Calif., Sept. 3 Bionovo, Inc. (Nasdaq: ... from the phase 2 clinical trial of their lead drug candidate for ... Society for Gynecology (EGS) in Rome, Italy. , ... the safety and efficacy of two doses of Menerba versus placebo. The ...
... WASHINGTON, Sept. 3 The International Medical Interpreters ... building the organization,s international structure. The IMIA is proud ... Representative for Brazil. A medical interpreter trained in the ... now undergoing a Masters Program at Santa Catarina Federal ...
... , , ... and Drug Administration,s quest to dramatically reduce Salmonella-related food poisoning, ... country,s largest shell egg pasteurizer, opened a new state-of-the-art plant ... to eggs free from dangerous egg-related Salmonella-enteritidis. , , ...
Cached Medicine News:Health News:Endo Pharmaceuticals Introduces VALSTAR(TM) (Valrubicin) To Fill Unmet Need In Aggressive Form of Bladder Cancer 2Health News:Endo Pharmaceuticals Introduces VALSTAR(TM) (Valrubicin) To Fill Unmet Need In Aggressive Form of Bladder Cancer 3Health News:Endo Pharmaceuticals Introduces VALSTAR(TM) (Valrubicin) To Fill Unmet Need In Aggressive Form of Bladder Cancer 4Health News:Endo Pharmaceuticals Introduces VALSTAR(TM) (Valrubicin) To Fill Unmet Need In Aggressive Form of Bladder Cancer 5Health News:Service Dogs Help Traumatized Veterans Heal 2Health News:Service Dogs Help Traumatized Veterans Heal 3Health News:Council for American Medical Innovation to Host Capitol Hill Breakfast Briefing on Education and Immigration: The Building Blocks of Innovation 2Health News:Bionovo to Present Positive Results from Phase 2 Trial of Menerba for Vasomotor Symptoms to the International Community 2Health News:Bionovo to Present Positive Results from Phase 2 Trial of Menerba for Vasomotor Symptoms to the International Community 3Health News:Bionovo to Present Positive Results from Phase 2 Trial of Menerba for Vasomotor Symptoms to the International Community 4Health News:IMIA Interpreter Association Appoints Brazil Representative 2Health News:National Pasteurized Eggs Increases Access to Safe Pasteurized Shell Eggs With New Plant Opening During September's National Food Safety Education Month 2
Each handle is designed to fit a specific trephine size....
20 GA TITANIUM RETINAL FORCEPS...
... German Craftsmanship have produced ... in the world. Ocutek ... to you! Only holders ... certificate, which requires and ...
... German Craftsmanship have produced ... in the world. Ocutek ... to you! Only holders ... certificate, which requires and ...
Medicine Products: